RxDoctor Payments Data

Audra Deveikis

Pediatric Infectious Diseases · Long Beach, CANPI 1558461327

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $16,450 of the $24,370 with a category attached, or 67.5%. Viiv Healthcare Company accounts for 76.8% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2023 at $9,240 and has fallen 98.5% since, to $138 in 2025. Among pediatric infectious diseases clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$24,370in general payments, 2019–2025

Across 191 payments — averaging $127.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Viiv Healthcare Company$19K
  • Merck$2K
  • AstraZeneca$2K
  • Johnson & Johnson$913
  • Gilead$714
  • EMD Serono, Inc.$93
  • plus $264 from 6 others
$876,145in research payments, 2019–2025

Across 123 payments — averaging $7123.13 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$320K
  • Janssen Research & Development, LLC$304K
  • AstraZeneca$153K
  • Astrazeneca UK Limited$61K
  • Paratek Pharmaceuticals, Inc.$37K
  • Pfizer$832

What the payments were for

  • Consulting fees$16,45068%
  • Travel & lodging$3,64315%
  • Food & beverage$4,24817%
  • Education$280%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$24,370 in reported general payments places this provider in the 90th percentile of 83 pediatric infectious diseases providers in California.

See all pediatric infectious diseases providers in California

Other pediatric infectious diseases in Long Beach

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →